HC Wainwright keeps Arrowhead Pharmaceuticals price target at $120.00
HC Wainwright & Co. maintained a $120.00/share price target for Arrowhead Pharmaceuticals, according to ratings actions
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.